United Therapeutics (NASDAQ: UTHR) pushes inhaled therapy strategy as Phase 3 Tyvaso data shows lung function preservation in IPF
Read More 2 minute read General business news UK insurtech company Concirrus raises $20m in Series B round Concirrus, a London based marine and automotive insurtech company, has raised $20 million in a Series B funding… byPallavi MadhirajuFebruary 23, 2020
